Laser Ablation for Small Hepatocellular Carcinoma : Table 1

Table 1: Studies reporting the outcome of Laser Ablation for small hepatocellular carcinoma.


Authors	Number of tumors/patients	Size of tumors (cm) mean (SD)	Local recurrence rate (%)	Complete ablation* (%)	Overall survival (%)		Major complications rate** (%)	Mortality rate (%)
					3-year	5-year

Giorgio et al. [76]	85/77	3.2 (1.0–6.6)	18	82.5⁺			3.7⁺	1.2⁺
Pacella et al. [80]	30/30	5.2 ± 0.0 (3.5–9.0)	7	90.0⁺ TACE	60.0^§		0	0
Pacella et al. [80]	15/30	1.9 ± 3.5 (0.8–3.0)	0	100.0			0	0
Pacella et al. [67]	92/74	2.4 ± 0.7 (0.8–4.0)	6	97.0	73.0^§	31.0^§	0	0
Eichler et al. [74]	39/61	>2.0	0	97.5	Mean 4.4 years		0	0
Dick et al. [64]	19/19			50.7^#	Mean 14.6 months^#
Pacella et al. [77]	169/148	2.6 ± 0.8	15	82.0	58.0^§	30.0^§	0.5	0.6
Pacella et al. [79]	548/432 (multicenric study)	2.4 ± 0.8	20	79.6		41.0^§	1.6	0.2

⁺Calculated in mix histologic tumor types (seventy-seven patients had hepatocellular carcinoma (HCC)). Twenty-seven had metastases from colocarcinoma () or lung ().
*Calculated per tumor.
**Calculated per patient.
^§Calculated in patients with Child-Turcotte-Pugh class A.
^#Calculated in mix histologic tumor types (nineteen patients had 19 HCCs, eleven patients had metastases from a variety of primary tumors, and five patients had metastatic carcinoid).